SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility and a sharp sell-off as investors aggressively rotate out of semiconductor stocks, raising concerns about the sustainability of the AI growth narrative. Community members are divided, with many attempting to aggressively buy the dip while others fear a larger, long-term breakdown in the sector.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as institutional interest builds around its potential to lead the psychedelic medicine sector, further fueled by favorable government policy shifts and anticipation of upcoming Phase 3 trial data. Investors are closely monitoring the stock's clinical milestones and commercialization strategy, with many in the community expressing strong conviction in the companys first-mover advantage and long-term valuation potential.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense downward pressure as investors react to a new 75 million share offering, which the company states is necessary to fund equity contributions for its U.S. Department of Energy loan and scale R2 production. While the community is dividedwith some bulls viewing this as a strategic move to unlock federal funding and others expressing deep frustration over immediate dilutionthe stock remains a high-conviction play for those focused on its long-term revenue growth and production scaling.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors focus on the potential for a major legal settlement with Pfizer following its recent deal with Moderna and speculation regarding a future buyout. Community discussion remains heavily centered on the company's valuation, frustration over stalled share price momentum, and widespread criticism of the current C-suite's transparency and perceived influence by major shareholders.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is trending as investors weigh explosive AI infrastructure demand against market valuation concerns and recent insider profit-taking. The community is actively debating the company's long-term leadership in semiconductor equipment versus potential cyclical overextension, closely monitoring how the stock holds key structural support levels amid broader sector rotation.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean is trending as investors digest a strong earnings report that featured raised revenue guidance for 2026 and an optimistic 30% growth target for 2027, signaling a pivot toward higher-margin AI inference workloads. While some community members remain skeptical of the stock's valuation and potential dilution, bulls are pointing to the company's successful shift into enterprise-level scaling and rapid growth in AI-native customer revenue.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending following a massive $10 billion acquisition by Vertex Pharmaceuticals, with shares rallying significantly as the market digests the all-cash deal. Community discussion is focused on the premium valuation, the successful exit for long-term holders, and speculation regarding which rare-disease biotech might be the next target for similar big pharma consolidation.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive $19 billion, 20-year lease agreement with AI firm Anthropic and the sale of a joint venture stake to strengthen its balance sheet. While investors are debating the stock's recent volatility and management's timing, the community is heavily focused on the company's strategic pivot from crypto mining to high-demand AI infrastructure and its potential for long-term repricing.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending as investors react to a recent earnings report highlighting revenue growth and a strategic pivot toward smart eyewear and defense, which has sparked speculation about potential upcoming customer design wins. While the community remains divided between those betting on a major breakout driven by production scaling and those skeptical of past execution delays, the stock is seeing significant volume and renewed bullish interest.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility and a sharp pullback as investors grapple with a sector-wide rotation out of high-flying AI memory stocks and react to Samsung's earnings results. The community is deeply divided, with many debating whether this is a structural shift in the industry cycle or a temporary panic-driven buying opportunity that ignores strong long-term fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


nh88cucncom

NH88